Lyra Therapeutics reports disappointing results for LYR-210 in Phase 3 chronic rhinosinusitis trial

Pallavi Madhiraju- May 7, 2024 0

Lyra Therapeutics, Inc. (Nasdaq: LYRA), dedicated to advancing treatments for chronic rhinosinusitis (CRS), announced that its Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 did not ... Read More

AstraZeneca Pharma India, Mankind Pharma announce distribution partnership for asthma medication Symbicort

Pallavi Madhiraju- March 12, 2024 0

AstraZeneca Pharma India Limited (AstraZeneca India) and Mankind Pharma Limited have embarked on a strategic collaboration for the exclusive distribution of AstraZeneca’s asthma medication, Symbicort ... Read More

Indoco Remedies’ Warren Remedies commences commercial production in Aurangabad

Pallavi Madhiraju- March 2, 2024 0

Warren Remedies Private Limited, a wholly-owned subsidiary of Indoco Remedies Limited, has officially started its commercial operations on March 1, 2024. The new Greenfield manufacturing ... Read More